EIM
PTLA

Essex Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Essex Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,659
Closed -$1.04M – 505
2019
Q4 		$1.04M Buy
43,659
+1,273
+3% +$35.1K 0.13% 223
2019
Q3 		$1.14M Buy
+42,386
New +$1.19M 0.16% 192

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Essex Investment Management's PTLA Position: Q1 2020 in Review

Essex Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 43,659 shares — an estimated $1.04M sold.

Essex Investment Management first reported a position in PTLA in Q3 2019 and held it in 2 quarters. The position peaked at $1.14M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Essex Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Essex Investment Management sold 43,659 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.04M.
  • Essex Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 2 quarters.
  • Essex Investment Management's Portola Pharmaceuticals, Inc. position peaked at $1.14M in Q3 2019.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Essex Investment Management's 13F filing for Q1 2020, filed 4 May 2020.